✦ LIBER ✦

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer

✍ Scribed by Pierga, J-Y; Lainé-Bidron, C; Beuzeboc, P; De Crémoux, P; Pouillart, P; Magdelénat, H

Book ID: 109837433
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 707 KB
Volume: 76
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1997.421

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous abdominal, but not femoral

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

✍ A. Mavri; M. C. Alessi; D. Bastelica; O. Geel-Georgelin; F. Fina; J. T. Sentocni 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 93 KB

Expression of plasminogen activator inhi

Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer: A favorable prognostic factor related to the actions of CSF-1

✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB 👁 2 views

In ovarian cancer cells, the macrophage colony-stimulating factor-1 (CSF-1) induces the release of plasminogen activator inhibitor-2 (PAI-2), and high levels of PAI-2 as well as of CSF-1 in ovarian cancer ascites are independently correlated with poor outcome. We now study the effect of CSF-1 on PAI

Cathepsin-D, urokinase plasminogen activ

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors

✍ Jahkola, T; Toivonen, T; Smitten, K von; Virtanen, I; Wasenius, V-M; Blomqvist, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 284 KB

Predicting pathological response to neoa

Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method

✍ Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Katsuya Maruyama; Eisuke Fukuma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

## Abstract ## Purpose: To assess the efficacy of quantitative ^1^H MR spectroscopy (MRS) using the external standard method to predict the pathological response to neoadjuvant chemotherapy with an anthracycline‐based regimen in breast cancer patients. ## Materials and Methods: Sixteen patients

Dedifferentiation of serous ovarian canc

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)

✍ Christer Borgfeldt; Stefan R. Hansson; Barbro Gustavsson; Anna Måsbäck; Bertil C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 1 views

The plasminogen activating system is involved in tumor growth and metastasis by degradation of extracellular matrix, and modulation of cell adhesion and migration. Benign and well-differentiated malignant ovarian tumors present as cystic lesions with preserved glandular morphology, whereas poorly di

Monitoring of early response to neoadjuv

Monitoring of early response to neoadjuvant chemotherapy in breast cancer with 1H MR spectroscopy: Comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography

✍ Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Toshihiro O'uchi; Naoko Kawano; Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract ## Purpose To assess the efficacy of ^1^H MR spectroscopy (MRS) to evaluate early responses to neoadjuvant chemotherapy in breast cancer patients, as compared to that of the standardized uptake value (SUV) in ^18^F‐fluorodeoxyglucose (FDG) positron emission tomography (PET). ## Materi